Stereotaxis, Inc. (STXS)

2,4500 -0,1300 (-5,04%) Al cierre: 04:00PM EDT

Stereotaxis, Inc.

710 North Tucker Boulevard
Suite 110
Saint Louis, MO 63101
United States
314 678 6100
https://www.stereotaxis.com

Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 122

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.	CEO & Chairman	62,2k	N/A	1987
Ms. Kimberly R. Peery	CFO & Secretary	251,76k	N/A	1969
Mr. Keith Galloway	Vice President of Operations	N/A	N/A	N/A
Ms. Laura Spencer Garth	General Counsel & Secretary	N/A	N/A	N/A
Mr. Guy Judkowski	Equity Portfolio Manager	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Gobierno corporativo

El ISS Governance QualityScore de Stereotaxis, Inc., a día 1 de abril de 2024, es 9. Las puntuaciones base son Auditoría: 8; Tablero: 8; Derechos de los accionistas: 9; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.